What this means for patients The practical issue is not Should all patients stop GLP-1 drugs? The better question is: Do I already have diabetic retinopathy, and do I need a retinal exam or closer follow-up while my diabetes treatment is being intensified? Who Needs Extra Eye Monitoring
This is the sweet spot for most individual researchers
Irrespective, the TJ did not appear to be affected morphologically in these mice (of either sex) and the barrier function of the intestinal epithelium (small and large intestine), based on electrophysiological measurements, also appeared normal
La OMS tambin aadi a la lista los anlogos de insulina de accin rpida, tambin fabricados por Novo Nordisk y Eli Lilly, entre otros, para el tratamiento de la diabetes tipo 1, tipo 2 y gestacional
Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension
Glycosylation of Ca V 3.2 channels contributes to the hyperalgesia in peripheral neuropathy of type 1 diabetes